C

Climb Bio Inc
D

CLYM

1.88000
USD
-0.12
(-5.76%)
مغلق
حجم التداول
45,672
الربح لكل سهم
-1
العائد الربحي
-
P/E
-94
حجم السوق
127,396,508
المقالات

العنوان: Climb Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.